On May 8, 2024, AbbVie Inc announced that it held its annual general meeting of shareholders on May 3, 2024 and declared voting results. The Company stated that the shareholders' proposal submitted by John Chevedden, on behalf of Kenneth Steiner, regarding a simple majority vote was not presented at the 2024 Annual Shareholder Meeting.